Skip to main content
TipRanks
Go Ultimate75% OFF

Arvee Laboratories (India) Ltd. (ARVEE) AI Stock Analysis

0 Followers
IN:ARVEE

Arvee Laboratories (India) Ltd.

(NSE:ARVEE)

Select Model
Rating:63Neutral
Price Target:INR 220.00â–¼(-0.90% Downside)
Action:reiterated
Date:09/29/26

The stock's strong technical momentum and robust balance sheet are offset by a very high valuation and weak cash flow generation. While the upward price trend and low debt are significant positives, the negative operating cash flow and expensive P/E ratio present considerable risks.

Positive Factors
Balance Sheet StrengthVery low leverage and steadily rising equity reduce financial fragility and preserve flexibility for operations or investment. This gives Arvee greater capacity to withstand earnings volatility and fund opportunities without relying heavily on incremental borrowing.
Negative Factors
Revenue VolatilitySharp revenue swings and repeated declines make the company’s growth profile less dependable over the next several quarters. Unstable sales reduce operating visibility, complicate resource planning, and can limit the sustainability of current profitability.

Arvee Laboratories (India) Ltd. (ARVEE) vs. iShares MSCI India ETF (INDA)

-20%0%20%40%60%80%IN:ARVEE+33.71%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 2.45B
Dividend Yield
―
Average Volume (3M)
15.96K
Price to Earnings (P/E)
37.1
Beta (1Y)
1.36
Revenue Growth
138.64%
EPS Growth
1536.16%
Country
India
Employees
57
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Arvee Laboratories (India) Ltd. Business Overview & Revenue Model

Company Description

Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer...

Arvee Laboratories (India) Ltd. Financial Statement Overview

Summary

Mixed financials: Strong balance sheet (Score 88) with minimal debt, but weakened by poor cash flow (Score 40) and moderate income performance (Score 62) due to revenue decline despite margin improvement.

Income Statement

62Positive

Balance Sheet

88Very Positive

Cash Flow

40Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue627.37M315.14M384.87M303.42M612.76M471.44M
Gross Profit183.33M111.68M121.63M41.49M173.09M142.99M
EBITDA86.53M31.98M42.69M30.46M86.34M61.30M
Net Income65.97M25.26M21.47M10.52M41.19M26.77M
Balance Sheet
Total Assets611.88M432.57M381.58M381.99M386.85M410.46M
Cash, Cash Equivalents and Short-Term Investments129.31M32.82M49.06M18.65M8.92M86.39M
Total Debt10.00M11.13M10.33M10.00M10.00M88.79M
Total Liabilities231.50M95.30M68.97M90.85M106.23M196.08M
Stockholders Equity380.38M337.88M312.61M291.14M280.62M214.38M
Cash Flow
Free Cash Flow0-29.02M-17.35M10.78M14.45M-5.80M
Operating Cash Flow0-694.00K1.19M36.64M29.29M17.11M
Investing Cash Flow02.17M-17.91M-21.63M-12.58M-6.04M
Financing Cash Flow0802.00K333.00K-1.88M-24.17M45.20M

Arvee Laboratories (India) Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price222.00

Price Trends

50DMA203.41Positive
100DMA183.31Positive
200DMA171.15Positive

Market Momentum

MACD6.58Negative
RSI56.99Neutral
STOCH64.93Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ARVEE, the sentiment is Positive. The current price of 222.00 is above the 20-day moving average (MA) of 209.12, above the 50-day MA of 203.41, and above the 200-day MA of 171.15, indicating a bullish trend. The MACD of 6.58 indicates Negative momentum. The RSI at 56.99 is Neutral, neither overbought nor oversold. The STOCH value of 64.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ARVEE.

Arvee Laboratories (India) Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:ARVEE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:TAINWALCHMIN:TAINWALCHM64NeutralINR 1.81B23.73―1.53%-17.16%3.36%
IN:ARVEEIN:ARVEE63NeutralINR 2.45B37.06――138.64%1536.16%
IN:PODDARMENTIN:PODDARMENT57NeutralINR 2.71B18.18―1.57%4.50%-17.13%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:VINEETLABIN:VINEETLAB47NeutralINR 729.65M14.98――6.45%―
IN:SRDIN:SRD46NeutralINR 2.99B16.18―0.11%19.82%92.88%
IN:AKSHARCHEMIN:AKSHARCHEM41NeutralINR 2.84B10.00―0.14%32.59%1397.90%

* General Sector Average

Performance Comparison

0%50%IN:ARVEEIN:AKSHARCHEMIN:PODDARMENTIN:SRDIN:TAINWALCHMIN:VINEETLABDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:ARVEE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:ARVEEArvee Laboratories (India) Ltd.222.0054.4332.48%
IN:AKSHARCHEMAksharChem India Ltd.353.2598.2138.51%
IN:PODDARMENTPoddar Pigments Limited255.60-4.09-1.58%
IN:SRDShankar Lal Rampal Dye-Chem Ltd.46.73-23.51-33.47%
IN:TAINWALCHMTainwala Chemicals & Plastics (India) Ltd193.00-0.43-0.22%
IN:VINEETLABVineet Laboratories Ltd.37.992.456.89%

Arvee Laboratories (India) Ltd. Corporate Events

Arvee Laboratories Fined by NSE for Technical SEBI Compliance Lapse

Oct 15, 2026

Arvee Laboratories (India) Ltd. operates in the chemicals and laboratory products sector from its base in Ahmedabad and is listed on the National Stock Exchange under the symbol ARVEE. The company functions within SEBI’s stringent listing and disclos...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 29, 2026